Dr. Malinda Lee

Fertility specialist Dr. Malinda Lee (REI) at Reproductive Science Center of the Bay Area

Malinda Lee, MD, MBA

Reproductive Endocrinologist (REI)

The team puts care and attention to detail into check-ins and the care regimen. I’m huge on clear communication and customer service, and this team never disappoints. IVF is already stressful, and the simple fact that you don’t have the added stress of chasing down responses or having more questions after instructions are given is just perfect.
From our patient survey

About Dr. Lee | Reproductive Endocrinologist

Dr. Malinda Lee earned her Bachelor of Science in biological sciences from Stanford University, graduating with honors and distinction. She later received both her medical degree at Harvard Medical School and a Master of Business Administration from Harvard Business School in Boston within the same year. She completed her residency in obstetrics and gynecology (OB/GYN) at Brigham and Women’s Hospital and Massachusetts General Hospital in Boston and went on to complete her fellowship in reproductive endocrinology & infertility (REI) at Brigham and Women’s Hospital.

Dr. Lee is accomplished in her education and has earned many awards, including outstanding teacher of obstetrics and gynecology three years in a row at Harvard Medical School. There, she was a member of the admissions committee and also served on the trainee quality and patient safety committee at Massachusetts General Hospital. Throughout her career, she’s authored nearly 30 peer-reviewed research publications, abstracts and poster presentations.

Her specialties include fertility preservation, egg donation and preimplantation genetic testing for aneuploidy (PGT-A). Her interest in reproductive endocrinology derives from the field’s blend of art and science, combining a level of technological advancement that is unique in medicine with meaningful and long-lasting physician-patient relationships. Dr. Lee values her time with her patients most and loves helping them build their families.

Her approach to treatment emphasizes individualized care and the trusting partnership between patient and provider. From the beginning, she evaluates their history, circumstances and future goals to formulate a plan for treatment. Her ability to listen to patients with a compassionate and open-minded perspective allows patients to feel safe to make personal decisions about their treatment, which is a huge component of superior fertility care.

Dr. Lee grew up in the East Bay Area through undergraduate college. After graduating from Stanford, she moved to Boston where she spent the next 12 years in medical school, business school and post-graduate training. Amid the peak of the coronavirus pandemic, she was able to move back home to the Bay Area to reunite with her family and continue her career.

Outside of work, she enjoys hiking, skiing, trying new restaurants and spending time with her husband, who she met in medical school, and their three children.

I am proud of being able to bring tailored, individualized fertility care to each patient, which takes into consideration their own circumstances and goals.
Dr. Lee

An introduction to fertility specialist Dr. Malinda Lee

An introduction to Dr. Malinda Lee (Chinese)


  • Bachelor of Science in biological sciences with honors and distinction: Stanford University
  • Doctor of Medicine: Harvard Medical School
  • Master of Business Administration: Harvard Business School
  • Resident in obstetrics and gynecology: Brigham and Women’s Hospital and Massachusetts General Hospital, Harvard Medical School
  • Fellowship in reproductive endocrinology & infertility: Brigham and Women’s Hospital, Harvard Medical School


  • George Hagan Memorial Summer Science Fellowship
  • Vice Provost of Undergraduate Education Research Grant, Stanford University
  • Institute for Healthcare Improvement National Forum of Quality Improvement Scholarship, Partners Healthcare Centers of Expertise
  • Outstanding Teacher of Obstetrics and Gynecology, 2015, 2016, 2017, Harvard Medical School
  • American Society for Reproductive Medicine (ASRM) Corporate Member Council In-Training Grant


      • DuBois KN, Abodeely M, Sakanari J, Craig CS, Lee MS, McKerrow JH, Sajid M. Identification of the major cysteine protease of Giardia and its role in encystation. J Biol Chem 2008 June; 283:18024-31. PMID 18445589.
      • Grone BP, Carpenter RE, Lee MS, Maruska KP, Fernald RD. Food deprivation explains effects of mouthbrooding on ovaries and steroid hormones, but not brain neuropeptide and receptor mRNAs, in an African cichlid fish. Horm Behav 2012 June; 62:18-26. PMID 22561338.
      • Clark RM, Lee MS, Rauh-Hain JA, Hall T, Boruta DM, Del Carmen MG, Goodman A, Schorge JO, Growdon WB. Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy. Gynecol Oncol 2015 March; 136(3):516-20. PMID 25475542.
      • Joseph N, Clark RM, Dizon DM, Lee MS, Goodman A, Boruta D Jr, Schorge JO, Del Carmen MG, Growdon WB. Delay in Chemotherapy Administration Impacts Survival in Elderly Patients with Epithelial Ovarian Cancer. Gynecol Oncol, 2015 June; 137(3):401-5. PMID 25839911.
      • Lee MS, Cantonwine D, Little SE, McElrath TF, Parry SI, Lim KH, Wilkins-Haug LE. Angiogenic markers in pregnancies conceived through in vitro fertilization. Am J Obstet Gynecol. 2015 August; 213(2):212.e1-8. PMID 25797229
      • Lee MS, Venkatesh KK, Growdon WB, Ecker JL, York-Best CM. Predictors of 30-day readmission following hysterectomy for benign and malignant indications at a tertiary care academic medical center. Am J Obstet Gynecol. 2016 May; 214(5):607.e1-607.e12. PMID 26704895.
      • Lee MS, Evans BT, Stern AD, Hornstein MD. Economic implications of the Society for Assisted Reproductive Technology embryo transfer guidelines: healthcare dollars saved by reducing iatrogenic triplets. Fertil Steril. 2016 July; 106(1):189-195.e3. PMID 27037461.
      • Toth TL, Lee MS, Bendikson K, Reindollar R; American Society for Reproductive Medicine Embryo Transfer Advisory Panel. Embryo Transfer Techniques: An ASRM Survey of Current Society for Assisted Reproductive Technology practices. Fertil Steril. 2017 April; 107(4): 1003-1011. PMID 28366408.
      • Lee MS, Farland L, Missmer S, Ginsburg ES. Limitations on the compensation of gamete donors: A public opinion survey. Fertil Steril. 2017 Jun; 107(6):1355-1363. PMID 2830693.
      • Insogna IG, Lee MS, Reimers RM, Toth TL. Neutral effect of body mass index on implantation rate after frozen-thawed blastocyst transfer. Fertil Steril. 2017 Nov; 108(5):770-776. PMID 28985909.
      • Lee MS, Cardozo ER, Karmon AE, Wright DL, Toth TL. The impact of transfer time on pregnancy outcomes in frozen embryo transfer cycles. Fertil Steril, 2018 Mar; 109(3):467-472.
      • Lee MS, Farland LV, Thomas AM, Ginsburg ES. Public perspectives on placing age limits on men and women seeking fertility treatment. Fertil Steril, 2019 Mar; 111(3):497-504. PMID 3061550.
      • Lee MS, Lanes A, Ginsburg ES, Fox JH. Delta-9 THC can be detected and quantified in the semen of men who are chronic users of inhaled cannabis. J Assist Reprod Genet, 2020 Jun; 37(6):1497-1504. PMID 3235125.
      • Lee MS, Lanes A, Dolinko A, Bailin A, Ginsburg ES. The impact of polycystic ovarian syndrome and body mass index on the absorption of recombinant follicle stimulating hormone. J Assist Reprod Genet, 2020 Jul. Online ahead of print. PMID 32623663.
      • Insogna IG, Lanes A, Lee MS, Ginsburg ES, Fox JH. Association of Fresh Embryo Transfers Compared With Cryopreserved-Thawed Embryo Transfers With Live Birth Rate Amogn Women Undergoing Asssisted Reproduction Using Freshly Retrieved Donor Oocytes. JAMA, 2021 Jan 12; 325(2):156-163. PMID 33433574.
      • Lee MS, Lofgren KT, Thomas A, Lanes A, Goldman R, Ginsburg ES, Hornstein MD. The cost-effectiveness of preimplantation genetic testing for aneuploidy in the United States: an analysis of cost and birth outcomes from 158,665 in vitro fertilization cycles. Am J Obstet Gynecol. 2021 Jul; 225(1):55.e1-55.e17. PMID 33539823.
      • George JS, Lee MS, Ashby RK, Goldman R, Ginsburg ES, Lanes A, Srouji SS. The impact of insurance mandates on donor oocyte utilization: an analysis of 39,338 donor oocytes cycles from the Society for Assisted Reproductive Technology registry. Am J Obstet Gynecol. 2022 Dec; 227(6):877.e1-877.e11. PMID 35863456.
      • Gustin S, Lee M, Westphal L. (2013). Differences in Fertility and Assisted Reproduction in South Asian Women. In Ethic Differences in Fertility and Assisted Reproduction. (pp. 105-113). New York, NY: Springer.


      • English
      • Conversational Mandarin